PL3171873T3 - Kompozycja zawierająca ester alfa-tokoferolu do zapobiegania i leczenia alergicznego nieżytu nosa - Google Patents

Kompozycja zawierająca ester alfa-tokoferolu do zapobiegania i leczenia alergicznego nieżytu nosa

Info

Publication number
PL3171873T3
PL3171873T3 PL15720286T PL15720286T PL3171873T3 PL 3171873 T3 PL3171873 T3 PL 3171873T3 PL 15720286 T PL15720286 T PL 15720286T PL 15720286 T PL15720286 T PL 15720286T PL 3171873 T3 PL3171873 T3 PL 3171873T3
Authority
PL
Poland
Prior art keywords
toacpherol
prevention
ester
treatment
composition containing
Prior art date
Application number
PL15720286T
Other languages
English (en)
Inventor
Giorgio Panin
Jürgen Lamprecht
Original Assignee
Bio.Lo.Ga. S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51589387&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3171873(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bio.Lo.Ga. S.R.L. filed Critical Bio.Lo.Ga. S.R.L.
Publication of PL3171873T3 publication Critical patent/PL3171873T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Undergarments, Swaddling Clothes, Handkerchiefs Or Underwear Materials (AREA)
PL15720286T 2014-07-22 2015-04-17 Kompozycja zawierająca ester alfa-tokoferolu do zapobiegania i leczenia alergicznego nieżytu nosa PL3171873T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI20141332 2014-07-22
EP15720286.2A EP3171873B1 (en) 2014-07-22 2015-04-17 Composition comprising an ester of alpha-tocopherol for prevention and treatment of allergic rhinitis
PCT/EP2015/058368 WO2016012110A1 (en) 2014-07-22 2015-04-17 Composition comprising an ester of alpha-tocopherol for prevention and treatment of allergic rhinitis

Publications (1)

Publication Number Publication Date
PL3171873T3 true PL3171873T3 (pl) 2020-07-13

Family

ID=51589387

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15720286T PL3171873T3 (pl) 2014-07-22 2015-04-17 Kompozycja zawierająca ester alfa-tokoferolu do zapobiegania i leczenia alergicznego nieżytu nosa

Country Status (26)

Country Link
US (1) US20170165226A1 (pl)
EP (1) EP3171873B1 (pl)
CN (1) CN106659709A (pl)
AR (1) AR101274A1 (pl)
AU (1) AU2015294663B2 (pl)
BR (1) BR112017001116A8 (pl)
CA (1) CA2955664C (pl)
CL (1) CL2017000058A1 (pl)
CO (1) CO2017000550A2 (pl)
CY (1) CY1122823T1 (pl)
DE (1) DE202014106007U1 (pl)
DK (1) DK3171873T3 (pl)
EA (1) EA201692486A1 (pl)
ES (1) ES2779525T3 (pl)
GE (1) GEP20186830B (pl)
HR (1) HRP20200380T1 (pl)
HU (1) HUE049588T2 (pl)
LT (1) LT3171873T (pl)
MX (1) MX369991B (pl)
PE (1) PE20170437A1 (pl)
PL (1) PL3171873T3 (pl)
PT (1) PT3171873T (pl)
RS (1) RS60103B1 (pl)
SI (1) SI3171873T1 (pl)
SM (1) SMT202000194T1 (pl)
WO (1) WO2016012110A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3468530A4 (en) 2016-06-10 2020-03-11 Clarity Cosmetics Inc. NON-COMEDOGEN FORMULA FOR HAIR AND SCALP CARE AND METHOD FOR USE

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364945A (en) * 1979-12-13 1982-12-21 Whittle Barry J Nasal composition for relieving nasal distress
US4269835A (en) * 1979-12-13 1981-05-26 Whittle Barry J Nasal composition for relieving nasal distress
US20100055152A1 (en) * 2008-08-26 2010-03-04 Trutek Corporation Antihistamine and antihistamine-like nasal application, products, and method
DE4327089A1 (de) * 1993-08-12 1995-02-16 Roshdy Ismail Mittel zur Behandlung von allergischen Erkrankungen der Atemwege
IT1282778B1 (it) * 1996-05-31 1998-03-31 Giorgio Panin Vitamina "e" acetato quale prodotto per applicazione topica
ITMI981586A1 (it) * 1998-07-10 2000-01-10 Giorgio Panin Vitamina e e suoi esteri per l'uso nel trattamento topico di patologie delle mucose
JP2003128552A (ja) * 2001-08-16 2003-05-08 Rohto Pharmaceut Co Ltd 粘膜適用組成物
WO2004045556A2 (en) 2002-11-20 2004-06-03 Board Of Regents, The University Of Texas System Methods for inhibiting allergic inflammation and other responses initiated by pollens, molds, and other non-animal derived allergens
JP2008266255A (ja) * 2007-04-24 2008-11-06 Project M:Kk アレルギー性疾患を予防および／または治療するための組成物
US20100076072A1 (en) 2008-07-25 2010-03-25 Northwestern University Compositions and methods of vitamin e administration
IT1393056B1 (it) * 2008-09-22 2012-04-11 Bio Lo Ga Srl Uso di vitamina e o suoi derivati per il controllo di artropodi
ITMI20090480A1 (it) * 2009-03-27 2010-09-28 Bio Lo Ga Srl Supporto tessile imbevuto di una composizione detergente/idratante
US10561720B2 (en) * 2011-06-24 2020-02-18 EpitoGenesis, Inc. Pharmaceutical compositions, comprising a combination of select carriers, vitamins, tannins and flavonoids as antigen-specific immuno-modulators

Also Published As

Publication number Publication date
CY1122823T1 (el) 2021-05-05
CA2955664A1 (en) 2016-01-28
US20170165226A1 (en) 2017-06-15
EA201692486A1 (ru) 2017-07-31
DE202014106007U1 (de) 2015-07-23
SI3171873T1 (sl) 2020-07-31
CO2017000550A2 (es) 2017-03-31
AR101274A1 (es) 2016-12-07
CA2955664C (en) 2022-09-06
RS60103B1 (sr) 2020-05-29
MX2017000906A (es) 2017-05-12
BR112017001116A2 (pt) 2018-01-23
BR112017001116A8 (pt) 2022-07-05
AU2015294663B2 (en) 2019-11-21
DK3171873T3 (da) 2020-03-16
HUE049588T2 (hu) 2020-10-28
EP3171873A1 (en) 2017-05-31
CL2017000058A1 (es) 2017-08-11
WO2016012110A1 (en) 2016-01-28
EP3171873B1 (en) 2019-12-25
SMT202000194T1 (it) 2020-05-08
AU2015294663A1 (en) 2017-01-19
MX369991B (es) 2019-11-27
HRP20200380T1 (hr) 2020-08-07
CN106659709A (zh) 2017-05-10
GEP20186830B (en) 2018-02-26
ES2779525T3 (es) 2020-08-18
PE20170437A1 (es) 2017-04-22
LT3171873T (lt) 2020-04-10
PT3171873T (pt) 2020-02-25

Similar Documents

Publication Publication Date Title
IL281793A (en) Use of cannabinoids in the treatment of epilepsy
IL259441A (en) Materials and methods for treatment of titin-based myopathies and other titinopaties
PL3277270T3 (pl) Kompozycje i sposoby leczenia niedokrwistości
PL3145522T3 (pl) Kombinacja, kompozycja i sposób podawania kombinacji lub kompozycji zwierzętom
PL3189074T3 (pl) Kompozycje oraz sposoby leczenia i zapobiegania zapaleniom
PL3157511T3 (pl) Zastosowanie kannabinoidów w leczeniu padaczki
SG11201707683YA (en) C/ebp alpha sarna compositions and methods of use
EP3302379A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF PTERYGIUM
HUE056172T2 (hu) Szelenoorganikus vegyületeket tartalmazó készítmények és eljárások alkalmazásukra
HUE055263T2 (hu) 11-Szubsztituált 24-hidroxiszterolok NMDA-hoz kapcsolódó állapotok kezelésére
PL3197987T3 (pl) Zastosowanie izomerycznie czystego lub izomerycznie wysoce wzbogaconego octanu cis- lub trans- 2-izobutylo-4-metylotetrahydropiran-4-ylu
SG11201702554QA (en) Compositions and methods for the treatment of multiple sclerosis
IL249364B (en) Pharmaceutical preparations that include dgla and their use
PL3373922T3 (pl) Kompozycje i sposoby do stosowania do leczenia homocystynurii
IL246587A0 (en) Preparations for use in the treatment of allergic conditions
SG11201809811VA (en) Compositions and methods for treatment of inflammation or infection of the eye
IL252779A0 (en) Prevention and treatment of inflammatory conditions
GB201621737D0 (en) Compositions and methods of treatment
DK3233104T3 (da) Immunterapi-behandlinger og -sammensætninger
IL261794A (en) Preparations and methods for using them
IL252707A0 (en) Compositions and methods for treating diseases and conditions
PL3171873T3 (pl) Kompozycja zawierająca ester alfa-tokoferolu do zapobiegania i leczenia alergicznego nieżytu nosa
EP3294417A4 (en) COMPOSITIONS AND METHOD FOR TREATING GLIOM
FI20145861A7 (fi) Multivalentteja yhdisteitä käytettäväksi aivovaurion hoidossa ja estämisessä
ITUB20160141A1 (it) Composizione per la prevenzione ed il trattamento di cefalee primarie